Announcement
01 Dec 2025
In December 2025, the U.S. Administration announced its commitments under an agreement on pharmaceutical pricing with the United Kingdom.
Source
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
01 Dec 2025
United Kingdom: UK Government’s commitments under an agreement on pharmaceuticals with the United States
08 May 2025
United Kingdom: UK Government's commitments under "Economic Prosperity Deal" with the United States
08 May 2025
United States of America: US Administration's commitments under "Economic Prosperity Deal" with the United Kingdom
01 Apr 2025
United States of America: Commerce Department initiates a Section 232 investigation into national security risks of pharmaceutical imports
See all
This state act is not part of any Thread yet.